Timucin Avsar - Publications

Affiliations: 
Bahcesehir University, School of Medicine, Department of Medical Biology 
Area:
Brain Tumors, hematopoietic stem cells

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Atabay KD, Yildiz MT, Avsar T, Karabay A, Kiliç T. Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells. Oncology Letters. 10: 2385-2389. PMID 26622856 DOI: 10.3892/Ol.2015.3512  0.371
2013 Karal-Yilmaz O, Ozkan A, Akgun E, Kukut M, Baysal K, Avsar T, Kilic T. Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. Journal of Materials Science. Materials in Medicine. 24: 147-53. PMID 23053813 DOI: 10.1007/S10856-012-4784-2  0.341
2012 Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay. Journal of Neurosurgery. 117: 697-704. PMID 22900848 DOI: 10.3171/2012.6.Jns112263  0.321
2011 Avsar T, Akgun E, Yılmaz OK, Küküt M, Baysal K, Bayir Y, Seker A, Kilic T. Abstract B48: Inhibition of recurrence of craniopharyngiomas with imatinib mesylate-loaded poly(lactide-co-glycolide) (PLGA) microspheres Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B48  0.333
2011 Avsar T, Atabay KD, Mehmet YT, Kilic T, Karabay AK. Abstract A31: Effects of Pin1 inhibition on tumorigenicity of glioblastoma multiforme Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A31  0.393
2011 Avsar T, Yener U, Akgun E. Abstract A30: Investigation of imatinib mesylate effect on vestibular schwannoma tumor by using in vivo corneal angiogenesis model Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A30  0.353
Show low-probability matches.